These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7675443)

  • 1. Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells.
    Suen KL; Bustelo XR; Barbacid M
    Oncogene; 1995 Sep; 11(5):825-31. PubMed ID: 7675443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
    Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1.
    Zhang Y; Saez R; Leal MA; Chan AM
    Oncogene; 1996 Jun; 12(11):2377-83. PubMed ID: 8649778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Raf/MAPK signaling in Xenopus oocyte extracts by Raf-1-specific peptides.
    Radziwill G; Steinhusen U; Aitken A; Moelling K
    Biochem Biophys Res Commun; 1996 Oct; 227(1):20-6. PubMed ID: 8858097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.
    Luo Z; Tzivion G; Belshaw PJ; Vavvas D; Marshall M; Avruch J
    Nature; 1996 Sep; 383(6596):181-5. PubMed ID: 8774885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes.
    Tobin D; Nilsson M; Toftgård R
    Oncogene; 1996 Feb; 12(4):785-93. PubMed ID: 8632900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 33-kDa C-terminal domain of Raf-1 protein kinase exhibits a Ras-independent serum- and phorbol ester-induced shift in gel mobility.
    Oláh Z; Ferrier A; Lehel C; Anderson WB
    Biochem Biophys Res Commun; 1995 Sep; 214(2):340-7. PubMed ID: 7545901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a transforming activity suppressing sequence in the c-raf oncogene.
    Ishikawa F; Sakai R; Ochiai M; Takaku F; Sugimura T; Nagao M
    Oncogene; 1988 Dec; 3(6):653-8. PubMed ID: 2577866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the 14.3.3 zeta domains important for self-association and Raf binding.
    Luo ZJ; Zhang XF; Rapp U; Avruch J
    J Biol Chem; 1995 Oct; 270(40):23681-7. PubMed ID: 7559537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain.
    Clark GJ; Drugan JK; Rossman KL; Carpenter JW; Rogers-Graham K; Fu H; Der CJ; Campbell SL
    J Biol Chem; 1997 Aug; 272(34):20990-3. PubMed ID: 9261098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of c-raf phosphoproteins in transformed murine cells.
    Schultz AM; Copeland T; Oroszlan S; Rapp UR
    Oncogene; 1988 Feb; 2(2):187-93. PubMed ID: 3285297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian Ras interacts directly with the serine/threonine kinase Raf.
    Vojtek AB; Hollenberg SM; Cooper JA
    Cell; 1993 Jul; 74(1):205-14. PubMed ID: 8334704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of Raf activity by binding of 14-3-3 to the amino terminus of Raf in vivo.
    Rommel C; Radziwill G; Moelling K; Hafen E
    Mech Dev; 1997 Jun; 64(1-2):95-104. PubMed ID: 9232600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.